Portfolio company
BrainQuant
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops artificial intelligence software that analyses magnetic resonance imaging sequences to detect neurodegenerative diseases for medical institutions and clinical researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
RebrAIn
The company develops artificial intelligence software to help neurosurgeons identify optimal brain targets for deep brain stimulation and lesioning treatments.
mediaire
This company develops artificial intelligence software for MRI scan analysis to assist radiologists in hospitals and clinics with diagnostic reporting.
Icometrix
This company develops artificial intelligence software that quantifies brain scans to assist radiologists and neurologists in monitoring neurological disorders and informing clinical decisions.
Combinostics
This company develops AI software for quantifying brain images and patient data to support clinicians in diagnosing and managing neurological disorders.
BrainKey
The company develops an artificial intelligence platform providing three-dimensional brain scan visualisations and neurological health insights for physicians and patients.
BrainQ
This company develops non-invasive, AI-guided electromagnetic neurorehabilitation devices and cloud-based monitoring platforms for stroke survivors and patients with neurological disorders to support recovery.
AIRS Medical
This company develops artificial intelligence software that accelerates magnetic resonance imaging scans and enhances image quality for hospitals and diagnostic imaging centres.
Brainomix
This company develops artificial intelligence imaging platforms for hospitals to automate the diagnosis and treatment of stroke and lung fibrosis.
